Viking Therapeutics Stock No-Brainer: Is It Worth Buying Below $35?
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
Discover which HYD ETF fits best for retirement planning with an eye on income stability and diversification. Learn key factors to compare and start building a resilient retirement portfolio.
22,937 articlesViking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
A surprising drop in Sandisk shares has many investors recalibrating their bets on memory chips. This guide explains ...
Grayscale argues that saylor’s strategy $1.5bb cashflow is being squeezed by a growing load of preferred-stock obliga...
A leading investor foresees a future where agentic AI unlocks massive productivity gains, enabling a company to reach...
SpaceX is expanding fast after its IPO, but new debt plans and strategic bets raise questions for investors. This art...
Investors are eyeing a potential rebound for Figma as enterprise adoption grows and AI-driven updates sharpen the pla...
A former Meta public policy director alleges the company spied on her for more than a year to suppress discussion of ...
Public family drama can hit the wallet as fast as headlines. This piece examines what the phrase 'tony says hopes bro...
Galaxy Research trims its forecast for the Clarity Act 2026 to 50% odds, citing a crowded Senate schedule and slow ne...
Axon Enterprise stock popped as investors weighed the company’s expanding product lineup, software growth, and a grow...
July can bring clear catalysts for Disney stock investors. This guide highlights three dates to watch, explains why t...
May 2026 hands investors a surprise: a big jump in M2 money supply could rekindle inflation pressures. Markets weigh ...